Abbott received FDA authorization for the Libre Duo 10 Day system, the world's first dual glucose-ketone sensing technology designed for ketone monitoring for people living with diabetes.
Public source
Publisher name
Public post
At Abbott, we're committed to making breakthrough technology more accessible. That's why I'm excited to see FDA authorization of Libre Duo 10 Day system, the world's fir…
Company
Abbott
- Industry
- Hospitals and Health Care
- Location
- Abbott Park, US
- Company size
- 10,001+ employees
About Abbott
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritional and branded generic medicines. Our 122,000 colleagues serve people in more than 160 countries. Connect with us at www.abbott.com, on Facebook at www.facebook.com/Abbott and www.facebook.com/AbbottCareers, on Instagram @AbbottGlobal, and on X @AbbottNews. We invite you to explore opportunities at Abbott, to see if your talents and career aspirations may fit with our openings. An equal opportunity employer, Abbott welcomes and encourages diversity in our workforce. Terms of Use: https://www.abbott.com/social-media-terms-of-use.html Privacy Policy: https://abbo.tt/privacy
See moreDiscover more
Similar signals
Similar public activity from other companies.
Legal & Regulatory
The diaTribe Foundation
The diaTribe Foundation reported that the FDA authorized Abbott's Libre Duo 10 Day sensor to continuously track glucose and ketones at once, serving as an early warning system for DKA.
Legal & Regulatory
Medical Device Manufacturing
Medical Device Manufacturing received FDA authorization for the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System, the first wearable to continuously monitor both glucose and ketone levels for patients aged 2 and older with diabetes.
Legal & Regulatory
ABIG Health
ABIG Health announced that the FDA cleared Abbott's Libre Duo, the first wearable that continuously tracks both glucose and ketones from a single sensor.
Legal & Regulatory
BioTrillion
BioTrillion was authorized by the FDA to use the Libre Duo wearable device to continuously measure glucose and ketones.
Legal & Regulatory
Calcium+Company